Advagene Biopharma Co (ROCO:6709) Scaled Net Operating Assets : 0.18 (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Advagene Biopharma Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Advagene Biopharma Co's operating assets for the quarter that ended in Jun. 2023 was NT$32.50 Mil. Advagene Biopharma Co's operating liabilities for the quarter that ended in Jun. 2023 was NT$7.15 Mil. Advagene Biopharma Co's Total Assets for the quarter that ended in Dec. 2022 was NT$140.84 Mil. Therefore, Advagene Biopharma Co's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2023 was 0.18.

Advagene Biopharma Co Scaled Net Operating Assets Historical Data

The historical data trend for Advagene Biopharma Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advagene Biopharma Co Scaled Net Operating Assets Chart

Advagene Biopharma Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.09

0.12

0.10

0.12

0.11

Advagene Biopharma Co Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial										0.10	0.15	0.16	0.18	0.17

Competitive Comparison of Advagene Biopharma Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Advagene Biopharma Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advagene Biopharma Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advagene Biopharma Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Advagene Biopharma Co's Scaled Net Operating Assets falls into.

Advagene Biopharma Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Advagene Biopharma Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(22.743	-	7.102)	/	140.838
=	0.11

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	147.934	-	125.191
=	22.743

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	7.972	-	0	-	0.87
=	7.102

Advagene Biopharma Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2023 )
=	(Operating Assets (Q: Jun. 2023 )	-	Operating Liabilities (Q: Jun. 2023 ))	/	Total Assets (Q: Dec. 2022 )
=	(32.495	-	7.145)	/	140.838
=	0.18

where

	Operating Assets		(Q: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	93.904	-	61.409
=	32.495

	Operating Liabilities		(Q: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8.771	-	0	-	1.626
=	7.145

Advagene Biopharma Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Advagene Biopharma Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Advagene Biopharma Co (ROCO:6709) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advagene Biopharma Co Ltd (ROCO:6709) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 6 Floor, No.308, Neihu District, Taipei, TWN, 114

Website

http://www.advagene.com.tw

Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based drug developer. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy), and other vaccines.

Advagene Biopharma Co (ROCO:6709) Headlines

No Headlines